J Clin Microbiol. 1991 November; 29(11): 2489-2493
Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada.
F E Ashton,
J A Ryan,
A Borczyk,
D A Caugant,
L Mancino and
D Huang
National Laboratory for Bacteriology, Laboratory Centre for Disease Control, Health and Welfare, Canada, Ottawa.
ABSTRACT
Multilocus enzyme electrophoresis was used to characterize 378 isolates of Neisseria meningitidis serogroup C recovered during a period of an increase in group C meningococcal disease in Canada. Thirty-four enzyme electrophoretic types were found among the isolates, which were predominantly (96.0%) serotype 2a. One clone (ET 15), characterized by a rarely occurring allele for the enzyme fumarase, was responsible for a focal outbreak in Ontario followed by the spread of group C disease across the province. This clone, which occurred infrequently among strains isolated in 1986, accounted for over 65% of group C strains associated with meningococcal disease in Canada in 1990.
J Clin Microbiol. 1991 November; 29(11): 2489-2493
This article has been cited by other articles:
-
Cameron, M. L., Tsang, R. S. W.
(2007). Analysis of Phenotypic Variants of the Serogroup C ET-15 Clone of Neisseria meningitidis by Pulsed-Field Gel Electrophoresis. J. Clin. Microbiol.
45: 2351-2352
[Full Text]
-
Elias, J., Vogel, U.
(2007). IS1301 Fingerprint Analysis of Neisseria meningitidis Strains Belonging to the ET-15 Clone. J. Clin. Microbiol.
45: 159-167
[Abstract]
[Full Text]
-
Law, D. K. S., Lorange, M., Ringuette, L., Dion, R., Giguere, M., Henderson, A. M., Stoltz, J., Zollinger, W. D., De Wals, P., Tsang, R. S. W.
(2006). Invasive Meningococcal Disease in Quebec, Canada, Due to an Emerging Clone of ST-269 Serogroup B Meningococci with Serotype Antigen 17 and Serosubtype Antigen P1.19 (B:17:P1.19).. J. Clin. Microbiol.
44: 2743-2749
[Abstract]
[Full Text]
-
Zhu, P., Boykins, R. A., Tsai, C.-M.
(2006). Genetic and functional analyses of the lgtH gene, a member of the {beta}-1,4-galactosyltransferase gene family in the genus Neisseria. Microbiology
152: 123-134
[Abstract]
[Full Text]
-
Yazdankhah, S. P., Lindstedt, B.-A., Caugant, D. A.
(2005). Use of Variable-Number Tandem Repeats To Examine Genetic Diversity of Neisseria meningitidis. J. Clin. Microbiol.
43: 1699-1705
[Abstract]
[Full Text]
-
De Wals, P., Deceuninck, G., Boulianne, N., De Serres, G.
(2004). Effectiveness of a Mass Immunization Campaign Using Serogroup C Meningococcal Conjugate Vaccine. JAMA
292: 2491-2494
[Abstract]
[Full Text]
-
Yazdankhah, S. P., Kriz, P., Tzanakaki, G., Kremastinou, J., Kalmusova, J., Musilek, M., Alvestad, T., Jolley, K. A., Wilson, D. J., McCarthy, N. D., Caugant, D. A., Maiden, M. C. J.
(2004). Distribution of Serogroups and Genotypes among Disease-Associated and Carried Isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J. Clin. Microbiol.
42: 5146-5153
[Abstract]
[Full Text]
-
Law, D. K. S., Henderson, A. M., Tsang, R. S. W.
(2004). DNA Sequence Analysis of the PorB Protein of Nonserotypeable Serogroup C ET-15 Meningococci Suggests a Potential Mutational Hot Spot on Their Serotype Antigens. J. Clin. Microbiol.
42: 2718-2723
[Abstract]
[Full Text]
-
Tsang, R. S. W., Tsai, C. M., Zhu, P., Ringuette, L., Lorange, M., Law, D. K. S.
(2004). Phenotypic and Genetic Characterization of a Unique Variant of Serogroup C ET-15 Meningococci (with the Antigenic Formula C:2a:P1.7,1) Causing Invasive Meningococcal Disease in Quebec, Canada. J. Clin. Microbiol.
42: 1460-1465
[Abstract]
[Full Text]
-
Tsang, R. S.W., Kiefer, L., Law, D. K. S., Stoltz, J., Shahin, R., Brown, S., Jamieson, F.
(2003). Outbreak of Serogroup C Meningococcal Disease Caused by a Variant of Neisseria meningitidis Serotype 2a ET-15 in a Community of Men Who Have Sex with Men. J. Clin. Microbiol.
41: 4411-4414
[Abstract]
[Full Text]
-
Jensen, E. S., Schonheyder, H. C., Lind, I., Berthelsen, L., Norgard, B., Sorensen, H. T.
(2003). Neisseria meningitidis phenotypic markers and septicaemia, disease progress and case-fatality rate of meningococcal disease: a 20-year population-based historical follow-up study in a Danish county. J Med Microbiol
52: 173-179
[Abstract]
[Full Text]
-
ALCALA, B., SALCEDO, C., ARREAZA, L., BERRON, S., FUENTE, L. D. L., VAZQUEZ, J.A.
(2002). The epidemic wave of meningococcal disease in Spain in 1996-1997: probably a consequence of strain displacement. J Med Microbiol
51: 1102-1106
[Abstract]
[Full Text]
-
TROTTER, C. L., FOX, A. J., RAMSAY, M. E., SADLER, F., GRAY, S. J., MALLARD, R., KACZMARSKI, E. B
(2002). Fatal outcome from meningococcal disease - an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. J Med Microbiol
51: 855-860
[Abstract]
[Full Text]
-
BALMER, P., BORROW, R., MILLER, E.
(2002). Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol
51: 717-722
[Abstract]
[Full Text]
-
De Wals, P., De Serres, G., Niyonsenga, T.
(2001). Effectiveness of a Mass Immunization Campaign Against Serogroup C Meningococcal Disease in Quebec. JAMA
285: 177-181
[Abstract]
[Full Text]
-
Jelfs, J., Munro, R., Wedege, E., Caugant, D. A.
(2000). Sequence Variation in the porA Gene of a Clone of Neisseria meningitidis during Epidemic Spread. CVI
7: 390-395
[Abstract]
[Full Text]
-
Vogel, U., Claus, H., Frosch, M., Caugant, D. A.
(2000). Molecular Basis for Distinction of the ET-15 Clone within the ET-37 Complex of Neisseria meningitidis. J. Clin. Microbiol.
38: 941-942
[Full Text]
-
van Deuren, M., Brandtzaeg, P., van der Meer, J. W. M.
(2000). Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management. Clin. Microbiol. Rev.
13: 144-166
[Abstract]
[Full Text]
-
Tondella, M. L. C., Reeves, M. W., Popovic, T., Rosenstein, N., Holloway, B. P., Mayer, L. W.
(1999). Cleavase Fragment Length Polymorphism Analysis of Neisseria meningitidis Basic Metabolic Genes. J. Clin. Microbiol.
37: 2402-2407
[Abstract]
[Full Text]
-
Vogel, U., Morelli, G., Zurth, K., Claus, H., Kriener, E., Achtman, M., Frosch, M.
(1998). Necessity of Molecular Techniques To Distinguish between Neisseria meningitidis Strains Isolated from Patients with Meningococcal Disease and from Their Healthy Contacts. J. Clin. Microbiol.
36: 2465-2470
[Abstract]
[Full Text]
-
Rosenstein, N., Levine, O., Taylor, J. P., Evans, D., Plikaytis, B. D., Wenger, J. D., Perkins, B. A.
(1998). Efficacy of Meningococcal Vaccine and Barriers to Vaccination. JAMA
279: 435-439
[Abstract]
[Full Text]
Copyright © 1991 by the American Society for Microbiology. All rights reserved.